Does Keflex (cephalexin) treat a methicillin‑resistant Staphylococcus aureus (MRSA) wound infection?

Keflex Does NOT Effectively Treat MRSA Wound Infections

No, Keflex (cephalexin) should not be used to treat MRSA wound infections because it lacks activity against methicillin-resistant Staphylococcus aureus. The IDSA guidelines explicitly recommend antibiotics with proven MRSA activity for these infections 1.

Why Cephalexin Fails Against MRSA

MRSA is resistant to all beta-lactam antibiotics, including cephalexin, by definition. The "methicillin-resistant" designation means the bacteria has altered penicillin-binding proteins that prevent beta-lactams from working 1. While the FDA label for Keflex lists Staphylococcus aureus as a susceptible organism 2, this only applies to methicillin-susceptible strains (MSSA), not MRSA.

What to Use Instead for MRSA Wounds

For Outpatient Purulent Wounds (abscesses, furuncles with drainage):

First-line oral options 1:

• TMP-SMX (trimethoprim-sulfamethoxazole) - Grade A-II evidence
• Doxycycline or minocycline - Grade A-II evidence
• Clindamycin - Grade A-I evidence (check local resistance rates; use only if <10% resistance)
• Linezolid - Grade A-II evidence (expensive, reserve for resistant cases)

Duration: 5-10 days based on clinical response 1

For Hospitalized Patients with Complicated Wound Infections:

IV options 1:

• Vancomycin - Grade A-I (first-line)
• Linezolid 600 mg IV/PO twice daily - Grade A-I
• Daptomycin 4 mg/kg IV daily - Grade A-I
• Clindamycin 600 mg IV/PO three times daily - Grade A-III

Duration: 7-14 days based on clinical response 1

Critical Caveat: Incision and Drainage is Key

The most important intervention for purulent MRSA wounds is incision and drainage (I&D) 1. Multiple studies show 85-90% cure rates with I&D alone, regardless of antibiotic choice 1. One placebo-controlled trial found 90.5% cure with I&D plus placebo versus 84.1% with I&D plus cephalexin for MRSA abscesses 3.

When Antibiotics ARE Needed After I&D 1:

• Severe/extensive disease involving multiple sites
• Rapid progression with surrounding cellulitis
• Systemic illness signs (fever, hypotension)
• Immunosuppression or significant comorbidities
• Extremes of age
• Difficult-to-drain locations (face, hand, genitalia)
• Lack of response to I&D alone

The Confusing Research on Cephalexin

Some studies show surprisingly good outcomes with cephalexin despite MRSA 4, 3, 5. A pediatric trial found no difference between cephalexin and clindamycin (94% vs 97% cure) for MRSA skin infections 4. Another study showed 84% cure with cephalexin for MRSA abscesses 3.

However, these results are misleading because:

1. Nearly all patients (97%) had I&D performed, which is the primary treatment 4
2. The studies enrolled only uncomplicated infections
3. Spontaneous drainage occurred in most cases
4. The high cure rates likely reflect adequate source control, not antibiotic efficacy

For cellulitis without drainage, the story is different. A retrospective study found cephalexin had only 74% success versus 91% for TMP-SMX in areas with high MRSA prevalence 6. The adjusted odds ratio for treatment failure with non-MRSA-active antibiotics was 4.22 6.

Practical Algorithm

Step 1: Is there purulent drainage or an abscess?

• Yes → Perform I&D immediately. This is more important than antibiotic choice.
• No → Proceed to Step 2

Step 2: Does the patient have risk factors requiring antibiotics (see list above)?

• No → I&D alone may suffice; close follow-up in 48-72 hours
• Yes → Prescribe MRSA-active antibiotic

Step 3: Choose antibiotic based on infection type:

• Purulent cellulitis/abscess → TMP-SMX or doxycycline (first-line for outpatients)
• Non-purulent cellulitis → Consider beta-lactam (cephalexin) FIRST, but switch to MRSA-active agent if no improvement in 48-72 hours 1
• Complicated/hospitalized → IV vancomycin

Common Pitfalls to Avoid

1. Don't skip I&D: Antibiotics alone, even MRSA-active ones, have poor penetration into abscesses
2. Don't use cephalexin for known MRSA: If cultures confirm MRSA, switch immediately to appropriate therapy
3. Don't assume all wound infections are MRSA: In areas with lower MRSA prevalence or for non-purulent cellulitis, beta-lactams remain reasonable first-line 1
4. Don't forget follow-up: Patients on cephalexin for presumed MSSA should be reassessed at 48-72 hours; lack of improvement mandates switching to MRSA-active therapy 1

Bottom line: Cephalexin is appropriate only for methicillin-susceptible Staphylococcus aureus (MSSA) wound infections, not MRSA. For empiric treatment when MRSA is suspected or confirmed, use TMP-SMX, doxycycline, or clindamycin for outpatients, with vancomycin reserved for severe or hospitalized cases 1.